Human acute lymphoblastic leukemia cells (MT-4)

HIV/AIDS research heavily relies on MT-4 cells to explore viral replication processes while studying host-pathogen interplay and developing antiretroviral treatments. MT-4 cells provide an optimal model system for testing antiviral drug effectiveness due to their vulnerability to HIV-1 infection. The study of immune evasion and viral latency mechanisms uses MT-4 cells as a research model. The scientific use of these cells extends into immunology research areas where they help study T-cell signaling pathways as well as apoptosis and immune response regulation. Drug discovery programs employ MT-4 cells to discover new compounds that may have therapeutic potential. MT-4 cells serve as an essential instrument in both viral infection research and the development of treatment methodologies.